The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Open accessAbstract
BACKGROUND: Colorectal cancer and type 2 diabetes share many risk factors, and hyperinsulinemia appears to be associated with an increased risk of colorectal cancer. We used the concentration of plasma C-peptide (an indicator of insulin production) to determine whether insulin and insulin resistance are associated with the risk of developing colorectal cancer. METHODS: We conducted a nested case-control study in the Physicians' Health Study. Plasma samples were collected from 14 916 cancer-free men from August 1982 through December 1984. Plasma C-peptide concentration, measured with an enzyme-linked immunosorbent assay, was available for 176 case patients who developed incident colorectal cancer through December 31, 1995, and 294 age- and smoking status-matched control subjects. Information on four other insulin resistance-related factors at baseline was obtained. We used conditional logistic regression models to investigate associations. All statistical tests were two-sided. RESULTS: Plasma C-peptide concentration was positively associated with age, body mass index (BMI), and number of insulin resistance-related factors, and it was inversely associated with fasting time before the blood draw, alcohol consumption, and vigorous exercise. An increased concentration of plasma C-peptide was statistically significantly associated with an increased risk of colorectal cancer (relative risk [RR] for the highest versus lowest quintile of plasma C-peptide = 2.7, 95% confidence interval [CI] = 1.2 to 6.2; P(trend) =.047), after adjusting for age, smoking status, fasting, BMI, alcohol consumption, vigorous exercise, and aspirin assignment in the Physicians' Health Study. The association became even stronger when the analysis was further adjusted for factors related to insulin resistance other than insulin levels (RR for the highest versus lowest quintile = 3.4, 95% CI = 1.4 to 8.3; P(trend) =.02) or when data from case patients who were diagnosed during the first 5 years of follow-up were excluded (RR for the highest versus the lowest quintile = 3.4, 95% CI = 1.3 to 8.8; P(trend) =.03). Adjusting for plasma levels of insulin-like growth factor I (IGF-I) and its binding protein 3 (IGFBP-3) did not materially change the results. There was no apparent modification of risk by BMI, insulin resistance-related factors, or vigorous exercise. CONCLUSION: Elevated insulin production, as reflected by elevated concentrations of plasma C-peptide, may predict the risk of developing colorectal cancer, independently of BMI, factors related to insulin resistance, or levels of IGF-I and IGFBP-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Self-citationCirculating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Self-citationLillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Dietary Fiber, Glycemic Load, and Risk of NIDDM in Men
Salmerón, J., Ascherio, A., Rimm, E. B., Colditz, G. A., Spiegelman, D., Jenkins, D. J., Stampfer, M. J., Wing, A. L., & Willett, W. C. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.545 · Cited by 1,426
Self-citationMa, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Self-citationPhysical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men
Giovannucci, E., Ascherio, A., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00002 · Cited by 1,013
Self-citationInsulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Self-citationLe Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
Fung, T. T., Rimm, E. B., Spiegelman, D., Rifai, N., Tofler, G. H., Willett, W. C., & Hu, F. B. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.1.61 · Cited by 871
Giovannucci, E. (1995) · Cancer Causes and Control · doi:10.1007/bf00052777 · Cited by 817
Self-citationInsulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Risk of Overweight Among Adolescents Who Were Breastfed as Infants
Gillman, M. W. (2001) · JAMA · doi:10.1001/jama.285.19.2461 · Cited by 772
Kaaks, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1592 · Cited by 653
(1980) · Environmental Pollution Series A, Ecological and Biological · doi:10.1016/0143-1471(80)90144-0 · Cited by 632
Eating Patterns and Risk of Colon Cancer
Slattery, M. L., Boucher, K. M., Caan, B. J., Potter, J. D., & Ma, K.-N. (1998) · American Journal of Epidemiology · doi:10.1093/aje/148.1.4-a · Cited by 561
Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer
Schoen, R. E., Tangen, C. M., Kuller, L. H., Burke, G. L., Cushman, M., Tracy, R. P., Dobs, A., & Savage, P. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1147 · Cited by 500
SUIKKARI, A.-M., KOIVISTO, V. A., RUTANEN, E.-M., YKI-JÄRVINEN, H., KARONEN, S.-L., & SEPPÄLÄ, M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-266 · Cited by 483
McKeown‐Eyssen, G. (1994) · PubMed · Cited by 460
Prospective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women
Hu, F. B., Manson, J. E., Liu, S., Hunter, D., Colditz, G. A., Michels, K. B., Speizer, F. E., & Giovannucci, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.542 · Cited by 423
Self-citationLeisure-Time Physical Activity, Body Size, and Colon Cancer in Women
Martinez, M. E., Giovannucci, E., Spiegelman, D., Willett, W. C., Hunter, D. J., & Colditz, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.948 · Cited by 419
Self-citationKiechl, S., Willeit, J., Poewe, W., Egger, G., Oberhollenzer, F., Muggeo, M., & Bonora, E. (1996) · BMJ · doi:10.1136/bmj.313.7064.1040 · Cited by 346
Specific binding of proinsulin C-peptide to human cell membranes
Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T., Nygren, P.-Å., Ståhl, S., Ekberg, K., Johansson, B.-L., Uhlén, S., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13318 · Cited by 328
Light-to-Moderate Alcohol Intake Is Associated With Enhanced Insulin Sensitivity
Facchini, F., Ida Chen, Y.-D., & Reaven, G. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.2.115 · Cited by 323
Body Mass Index and Colon Cancer Mortality in a Large Prospective Study
Murphy, T. K. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.9.847 · Cited by 321
Nilsen, T. I. L., & Vatten, L. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1582 · Cited by 292
Insulin Resistance with Aging: Effects of Diet and Exercise
Ryan, A. S. (2000) · Sports Medicine · doi:10.2165/00007256-200030050-00002 · Cited by 282
Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men
Platz, E. A., Willett, W. C., Colditz, G. A., Rimm, E. B., Spiegelman, D., & Giovannucci, E. (2000) · Cancer Causes & Control · doi:10.1023/a:1008999232442 · Cited by 280
Self-citationInsulin promotion of colon tumors in rats.
Tran, T. T., Medline, A., & Bruce, W. R. (1996) · PubMed · Cited by 275
Colorectal Cancer: Another Complication of Diabetes Mellitus?
Will, J. C., Galuska, D. A., Vinicor, F., & Calle, E. E. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009534 · Cited by 274
Colorectal cancer mortality and factors related to the insulin resistance syndrome.
Colangelo, L. A., Gapstur, S. M., Gann, P. H., Dyer, A. R., & Liu, K. (2002) · PubMed · Cited by 250
Mukherjee, P., Sotnikov, A. V., Mangian, H. J., Zhou, J.-R., Visek, W. J., & Clinton, S. K. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.512 · Cited by 237
Miele, C., Rochford, J. J., Filippa, N., Giorgetti-Peraldi, S., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000805200 · Cited by 216
Wolever, T. M. S., & Bolognesi, C. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.11.2807 · Cited by 214
Markers of insulin resistance and colorectal cancer mortality.
Trevisan, M., Liu, J., Muti, P. C., Misciagna, G., Menotti, A., & Fucci, F. (2001) · PubMed · Cited by 189
Mechanisms Linking Diet and Colorectal Cancer: The Possible Role of Insulin Resistance
Bruce, W. R., Wolever, T. M. S., & Giacca, A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_2 · Cited by 172
C-Peptide Measurement: Methods and Clinical Utility
Bonser, A. M., Garcia‐Webb, P., & Harrison, L. C. (1984) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368409165766 · Cited by 165
Diabetes mellitus and colorectal cancer risk.
Vecchia, C. L., Negri, E., Decarli, A., & Franceschi, S. (1997) · PubMed · Cited by 145
Extraction of Insulin by Liver
Field, J. B. (1973) · Annual Review of Medicine · doi:10.1146/annurev.me.24.020173.001521 · Cited by 136
Smith, G. D., Egger, M., Shipley, M. J., & Marmot, M. G. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116576 · Cited by 114
Dietary patterns and colon cancer in western New York
Randall, E., Marshall, J. R., Brasure, J., & Graham, S. (1992) · Nutrition and Cancer · doi:10.1080/01635589209514227 · Cited by 92
Random C-peptide in the classification of diabetes
B. Berger, G. S. (2000) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510050216411 · Cited by 86
Influence of Ageing on Glucose Homeostasis*
Jackson, R. A., BLIX, P. M., MATTHEWS, J. A., HAMLINGS, J. B., DIN, B. M., BROWN, D. C., BELIN, J., Rubenstein, A. H., & Nabarro, J. D. N. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-840 · Cited by 76
Tran, T. T., Gupta, N., Goh, T. T., Naigamwalla, D. Z., Chia, M. C., Koohestani, N., Mehrotra, S., McKeown‐Eyssen, G., Giacca, A., & Bruce, W. R. (2003) · PubMed · Cited by 74
Kinetics of Human C-peptide in Man
FABER, O. K., Kehlet, H., Madsbad, S., & Binder, C. (1978) · Diabetes · doi:10.2337/diab.27.1.s207 · Cited by 64
Koohestani, N. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1679 · Cited by 37
Kaaks, R. (2002) · PubMed · Cited by 26
Tang, Z., Shivapurkar, N., Frost, A. R., & Alabaster, O. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514437 · Cited by 23
Cited by
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Self-citationDiabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Molecular mechanisms of cancer development in obesity
Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3174 · Cited by 907
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706
Metadata
- Authors
- Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-06
- Volume
- 96
- Issue
- 7
- Pages
- 546-553
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2153051732
- Cited by
- 329
- References
- 50
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.